Company: ADZCF
Filing Date: 2025-11-26
Form Type: 424B2
Source: 0000950103-25-015315
Chunk: 17

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-11-26
Form: 424B2
Chunk 17
---
 well as any amounts payable on the Securities. See
“Description of Securities — Adjustments to Valuation Dates and Payment Dates — Change-in-Law Event for Non-U.S. Equity
Based Underlyings or Basket Components” in the accompanying product supplement.

Risks Relating to Conflicts of Interest

| · | Trading                                                                                            
 and Other Transactions by Us, UBS or Our or Its Affiliates in the Equity and Equity Derivative     
 Markets May Impair the Value of the Securities — We or our affiliates expect to                    
 hedge our exposure from the Securities by entering into equity and equity derivative transactions, 
 such as over-the-counter options, futures or exchange-traded instruments with one or more          
 hedge counterparties, which will include UBS or its affiliates. We, UBS or our or its affiliates   
 may also engage in trading in instruments linked or related to the Underlyings on a regular        
 basis as part of our or their general broker-dealer and other businesses, for proprietary          
 accounts, for other accounts under management or to facilitate transactions for customers,         
 including block transactions. Such trading and hedging activities may adversely affect the         
 values of the Underlyings and, therefore, make it less likely that you will receive a positive     
 return on your investment in the Securities. It is possible that we, UBS or our or its affiliates  
 could receive substantial returns from these hedging and trading activities while the value        
 of the Securities declines. We, UBS or our or its affiliates may also issue or underwrite          
 other securities or financial or derivative instruments with returns linked or related to          
 the Underlyings. To the extent that we, UBS or our or its affiliates serve as issuer, agent        
 or underwriter for such securities or financial or derivative instruments, our, UBS’               
 or our or its affiliates’ interests with respect to such products may be adverse to                
 those of the holders of the Securities. Introducing competing products into the marketplace        
 in this manner could adversely affect the values of the Underlyings and the value of the           
 Securities. Any of the foregoing activities described in this paragraph may reflect trading        
 strategies that differ from, or are in direct opposition to, investors’ trading and                
 investment strategies related to the Securities. Furthermore, because DBSI, UBS or one of          
 its affiliates is expected to conduct trading and hedging activities for us in connection          
 with the Securities, DBSI, UBS or such affiliates may profit in connection with such trading       
 and hedging activities and such